Literature DB >> 3091925

Direct identification of propionylcarnitine in propionic acidaemia: biochemical and clinical results of oral carnitine supplementation.

M Duran, D Ketting, T E Beckeringh, D Leupold, S K Wadman.   

Abstract

Urinary short-chain acylcarnitine in a patient with propionic acidaemia and low levels of free carnitine was found to consist mainly of propionylcarnitine. The compound was isolated by sequential paper and thin layer chromatography and identified by ammonia desorption chemical ionization mass spectrometry. Treatment of the patient with oral carnitine supplements led to a near-normalization of the plasma free carnitine concentrations and an increase in his muscle tone. The propionylcarnitine excretion rose and there was a simultaneous decrease in the methylcitrate output. Carnitine treatment did not prevent the occurrence of an episode of metabolic decompensation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091925     DOI: 10.1007/bf01799460

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  12 in total

1.  Propionylcarnitine. Physiological variations in vivo.

Authors:  T Bohmer; J Bremer
Journal:  Biochim Biophys Acta       Date:  1968-05-01

2.  The identification of acylcarnitines by desorption chemical ionization mass spectrometry.

Authors:  M Duran; D Ketting; L Dorland; S K Wadman
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

3.  Biochemical evidence of carnitine effect on propionate elimination.

Authors:  N Sugiyama; H Morishita; S Nagaya; T Nakajima; A Kawase; A Ohya; S Sugiyama; K Kamiya; I Watanabe; H Togari
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

4.  Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency.

Authors:  S Di Donato; M Rimoldi; B Garavaglia; G Uziel
Journal:  Clin Chim Acta       Date:  1984-05-16       Impact factor: 3.786

5.  L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia.

Authors:  C R Roe; D S Millington; D A Maltby; T P Bohan; C L Hoppel
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

6.  Hepatic ketogenesis and muscle carnitine deficiency.

Authors:  S DiDonato; F Cornelio; G Storchi; M Rimoldi
Journal:  Neurology       Date:  1979-06       Impact factor: 9.910

7.  Application of high resolution fast atom bombardment and constant B/E ratio linked scanning to the identification and analysis of acylcarnitines in metabolic disease.

Authors:  D S Millington; C R Roe; D A Maltby
Journal:  Biomed Mass Spectrom       Date:  1984-05

8.  Isovalerylglucuronide, a new urinary metabolite in isovaleric acidemia. Identification problems due to rearrangement reactions.

Authors:  L Dorland; M Duran; S K Wadman; A Niederwieser; L Bruinvis; D Ketting
Journal:  Clin Chim Acta       Date:  1983-10-31       Impact factor: 3.786

9.  The variability of metabolite excretion in propionicacidaemia.

Authors:  M Duran; D Gompertz; L Bruinvis; D Ketting; S K Wadman
Journal:  Clin Chim Acta       Date:  1978-01-02       Impact factor: 3.786

10.  Thermospray liquid chromatography/mass spectrometry for the analysis of L-carnitine and its short-chain acyl derivatives.

Authors:  A L Yergey; D J Liberato; D S Millington
Journal:  Anal Biochem       Date:  1984-06       Impact factor: 3.365

View more
  3 in total

1.  Comparison of mouse urinary metabolic profiles after exposure to the inflammatory stressors γ radiation and lipopolysaccharide.

Authors:  Evagelia C Laiakis; Daniel R Hyduke; Albert J Fornace
Journal:  Radiat Res       Date:  2011-11-30       Impact factor: 2.841

2.  Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients.

Authors:  W Lehnert; W Sperl; T Suormala; E R Baumgartner
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

3.  L-carnitine in inborn errors of metabolism: what is the evidence?

Authors:  J H Walter
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.